Toshikazu Kondo Selected Research

Toshikazu Kondo Research Topics

Disease

20	Wounds and Injuries (Trauma) 01/2022 - 07/2002
12	Thrombosis (Thrombus) 03/2021 - 02/2010
12	Neoplasms (Cancer) 10/2020 - 11/2002
7	Necrosis 01/2010 - 08/2002
5	Venous Thrombosis (Deep-Vein Thrombosis) 01/2017 - 02/2010
4	Colitis 07/2010 - 03/2004
4	Hemorrhage 01/2010 - 10/2006
3	Myocardial Infarction 02/2022 - 11/2017
3	Drowning 03/2021 - 01/2009
3	Carcinogenesis 10/2020 - 02/2008
3	Pulmonary Fibrosis (Fibrosing Alveolitis) 12/2017 - 03/2006
3	Acute Kidney Injury (Acute Renal Failure) 11/2012 - 02/2005
3	Poisoning 09/2012 - 03/2008
3	Neoplasm Metastasis (Metastasis) 05/2010 - 11/2002
3	Fibrosis (Cirrhosis) 01/2007 - 05/2002
2	Skin Neoplasms (Skin Cancer) 10/2020 - 04/2009
2	Ovarian Neoplasms (Ovarian Cancer) 04/2019 - 11/2015
2	Inflammation (Inflammations) 08/2017 - 02/2008
2	Enteritis 01/2011 - 03/2004
2	Colonic Neoplasms (Colon Cancer) 02/2008 - 11/2002
2	Lung Injury 06/2006 - 03/2006
2	Brain Injuries (Brain Injury) 04/2003 - 12/2002
1	ST Elevation Myocardial Infarction 02/2022
1	Arthralgia (Joint Pain) 02/2022
1	AIDS-Related Complex (ARC) 02/2022
1	No-Reflow Phenomenon 02/2022
1	Necrotizing Fasciitis 02/2022
1	Myocardial Ischemia (Ischemic Heart Diseases) 11/2021
1	Abdominal Aortic Aneurysm 11/2020
1	Asphyxia (Suffocation) 01/2019
1	Premature Obstetric Labor (Premature Labor) 01/2018
1	Cardiomegaly (Heart Hypertrophy) 01/2018

Drug/Important Bio-Agent (IBA)

11	CytokinesIBA 11/2020 - 09/2003
10	CollagenIBA 03/2021 - 07/2002
10	ChemokinesIBA 11/2020 - 04/2003
10	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2020 - 07/2002
7	Proteins (Proteins, Gene)FDA Link 03/2021 - 11/2002
7	AntibodiesIBA 03/2020 - 05/2003
6	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 06/2012 - 05/2002
5	Interleukin-6 (Interleukin 6)IBA 01/2019 - 09/2008
4	LigandsIBA 04/2019 - 04/2004
4	Messenger RNA (mRNA)IBA 01/2019 - 11/2002
4	Matrix Metalloproteinases (MMPs)IBA 01/2019 - 09/2010
4	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 11/2018 - 05/2002
4	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 10/2009 - 07/2002
4	Acetaminophen (Paracetamol)FDA LinkGeneric 01/2009 - 08/2002
4	Transforming Growth Factor beta1 (TGF beta 1)IBA 01/2007 - 07/2002
3	recombinant human tumor necrosis factor-binding protein-1IBA 11/2018 - 05/2002
3	Chemokine ReceptorsIBA 12/2017 - 03/2007
3	Collagen Type I (Type I Collagen)IBA 01/2017 - 04/2004
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 02/2012 - 03/2007
3	Dextran SulfateIBA 07/2010 - 02/2008
2	CholesterolIBA 02/2022 - 01/2020
2	Heme Oxygenase-1IBA 11/2021 - 01/2011
2	Aquaporins (Water Channels)IBA 03/2021 - 01/2018
2	Matrix Metalloproteinase 9 (Gelatinase B)IBA 10/2020 - 11/2002
2	Chemotactic FactorsIBA 12/2019 - 01/2011
2	Etanercept (Enbrel)FDA Link 11/2018 - 02/2008
2	indium-bleomycinIBA 12/2017 - 03/2007
2	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 08/2017 - 10/2009
2	CC ChemokinesIBA 11/2015 - 03/2007
2	Cisplatin (Platino)FDA LinkGeneric 11/2012 - 01/2004
2	Dihydrotachysterol (AT 10)IBA 07/2011 - 01/2004
2	Neutralizing AntibodiesIBA 01/2011 - 09/2008
2	Biological ProductsIBA 12/2010 - 03/2007
2	HerbicidesIBA 06/2010 - 03/2006
2	CreatinineIBA 01/2010 - 10/2006
2	NitrogenIBA 01/2010 - 10/2006
2	Urea (Carbamide)FDA LinkGeneric 01/2010 - 10/2006
2	CCR2 ReceptorsIBA 10/2009 - 04/2004
2	AzoxymethaneIBA 10/2009 - 02/2008
2	NF-kappa B (NF-kB)IBA 09/2008 - 06/2007
2	Monoclonal AntibodiesIBA 01/2007 - 06/2003
2	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 01/2007 - 12/2004
2	multidrug resistance-associated protein 1IBA 10/2006 - 02/2005
2	sodium arsenite (sodium metaarsenite)IBA 10/2006 - 02/2005
2	Monocyte Chemoattractant ProteinsIBA 04/2004 - 05/2003
1	LipidsIBA 02/2022
1	Hyaluronic Acid (Hyaluronan)IBA 02/2022
1	UbiquitinIBA 01/2022
1	PolymersIBA 11/2020
1	Hemostatics (Antihemorrhagics)IBA 11/2020
1	anthraceneIBA 10/2020
1	Transforming Growth Factors (Transforming Growth Factor)IBA 12/2019
1	Angiogenesis Inducing Agents (Angiogenesis Factor)IBA 12/2019
1	Sodium Bicarbonate (Baking Soda)FDA LinkGeneric 01/2019
1	Peptide Hydrolases (Proteases)FDA Link 01/2019
1	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 01/2019
1	PlasticsIBA 01/2019
1	Citric Acid (Citrate)FDA LinkGeneric 01/2019
1	LipopolysaccharidesIBA 01/2018
1	InterferonsIBA 01/2018
1	Bleomycin (Blenoxane)FDA LinkGeneric 12/2017
1	Nandrolone (Nortestosterone)IBA 11/2017

Therapy/Procedure

4	Ligation 03/2021 - 09/2008
2	Therapeutics 04/2019 - 01/2004
2	Subcutaneous Injections 01/2010 - 10/2006
1	Intra-Articular Injections 02/2022
1	Percutaneous Coronary Intervention 02/2022
1	Surgical Tape 11/2020